| (210) | Number of the EPO application | 16721603 |
| (220) | Filing date of the EPO application | 2016.04.28 |
| (80) | EPO patent specification publication (B) | EPB nr. 19/2020, 2020.05.06 |
| (110) | EPO patent number | 3288936 |
| (21) | Number of the application | e 2018 0231 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (72) | Name(s) of inventor(s), code of the country | RAVULA Suchitra, US;
SWANSON Devin M., US;
SAVALL Bradley M., US;
AMERIKS Michael K., US; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (54) | Title of the invention | BENZIMIDAZOLONE AND BENZOTHIAZOLONE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 403/12 (2006.01.01); C07D 401/04 (2006.01.01); C07D 401/10 (2006.01.01); C07D 235/26 (2006.01.01); C07D 403/10 (2006.01.01); C07D 413/10 (2006.01.01); C07D 417/04 (2006.01.01); C07D 417/10 (2006.01.01); C07D 417/12 (2006.01.01); C07D 498/08 (2006.01.01); C07D 277/68 (2006.01.01); A61K 31/4184 (2006.01.01); A61K 31/4245 (2006.01.01); A61K 31/428 (2006.01.01); A61P 25/00 (2006.01.01) |
| (19) | Country | BE |
| (41) | Date of publication of the application | 2018.04.30 |
| (30) | Priority | 201562154291 P, 2015.04.29, US |
| (86) | International application | PCT/US2016/029780, 2016.04.28 |
| (87) | International publication | WO 2016/176449, 2016.11.03 |